In drug discovery, a research director faces considerable challenges trying to make consistently good decisions concerning target selection. The task is comparable to a treasure hunt with many ...

A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.

UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

was on drug target validation strategies and technology such as high throughput assays and biomarkers that are enabling scientists to make predictions about the utility of new compounds earlier in the ...

A US clinical-stage biotechnology company has introduced the first bipedal humanoid robot in its AI-driven, fully automated ...

Three Gallaudet Biology students won honors and cash prizes in this year's NASA DC Space Grant Consortium’s student poster ...

Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

MSD says it has invested in the UK because of the excellence of its drug discovery, and finding a British scientist to lead its new centre helps back up the country’s claim to world-leading status.

A new company has entered the drug discovery space with what it calls a “chemistry-first” platform. Colorado-based Cime Therapeutics has emerged from stealth with $2.1 million in preseed financing to ...

By using those technologies, scientists at the United Kingdom’s Oxford Drug Discovery Institute can speed up the work of digging through journals and databases by nearly ten times—helping to ...